Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-09

Clinical Trial Update: Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tranexamic acid for prevention of postpartum hemorrhage in elective cesarean section has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: KK Women's and Children's Hospital | Conditions: Postpartum Hemorrhage, Tranexamic Acid | Phase 3 | Status: COMPLETED